Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Inquiry Memorial
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
Support and FAQs
NHS Psychological Support
Support Groups
Infected Blood Support Schemes
Hepatitis C Testing
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Dr Kirk provided information in 1976 to the Bournemouth Department of Pathology about a pupil who was negative for HbsAg and HBsAb and had a presumptive diagnosis of non-B hepatitis "probably associated with the transfusion of Kryobulin".
Published on:
16 July, 2024
Dr Painter spoke to some parents in early 1978, and appeared to regard Hepatitis B which had become chronic as potentially leading to a grim future, and a matter of significant concern.
Published on:
16 July, 2024
Dr Craske highlighted to Dr Aromstam that mixing the blood products of different manufacturers might increase the risks of hepatitis and advised that it might be wise to confine students to one type of material.
Published on:
08 October, 2024
Dr Craske asked for people with mild haemophilia to be given NHS Factor 8 for non-urgent operations such as tooth extraction, saying "We have found from observations at Oxford that this is the best way of finding out whether the material is associated with cases of hepatitis".
Published on:
16 July, 2024
Dr Aronstam disagreed with giving mild haemophiliacs NHS Factor 8 for non-urgent operations as he didn't want them to develop hepatitis in any form.
Published on:
16 July, 2024
Dr Craske suggested a trial of NHS concentrate be made to cover non-urgent operations, where other concentrates such as commercial material would be indicated.
Published on:
16 July, 2024
At the 17th meeting of the Haemophilia Reference Centre Directors, at which Dr Aronstam was present, the increased use of cryoprecipitate was discussed in the light of the first known death of a haemophiliac in the UK from AIDS.
Published on:
16 July, 2024
Dr Aronstam switched from using unheated commercial product to using heat treated commercial product (although he continued to use unheat-treated NHS concentrate).
Published on:
16 July, 2024
Dr Aronstam informed Dr Ahmed a patient had lost movement in both of his elbows and shoulders as a direct consequence of him not treating himself properly due to a fear of contracting AIDS, recording that he had advised the patient of "the very small risk numerically" of him acquiring the disease.
Published on:
16 July, 2024
In a letter to Dr Barnes, Dr Aronstam discussed concerns raised by Dr Barnes about Factor VIII affecting "T" cells, noting that the risk was very small and should not deflect from providing appropriate treatment.
Published on:
08 October, 2024
Dr Aronstam wrote to Dr Snape to enquire about a specially accredited pool of Factor 8 donors for new and mild haemophiliacs.
Published on:
16 July, 2024
Dr Snape wrote to Dr Lane discussing a letter from Dr Aronstam regarding the use of hepatitis-reduced Factor 8 where he highlights his immediate concern being securing Factor 8 for two untreated babies, additionally, he was prepared to enter suitable pupils from the College for a prospective hepatitis-reduced product study.
Published on:
08 October, 2024
Dr Aronstam wrote to Professor Bloom confirming that a patient was on the accredited donor pool long before heat treatment became available, it was also confirmed that the patient remained HTLV-3 antibody free.
Published on:
16 July, 2024
Dr Aronstam expressed reservations as to whether it was ethically right in "the current climate" to continue a patients's tolerance inducing protocol.
Published on:
16 July, 2024
Professor Bloom informed Dr Aronstam that a Treloar's pupil had received some of the same batch as the Cardiff patient who had developed AIDS.
Published on:
16 July, 2024
Staff at Treloar's indicated to students sitting together in a large room whether they were HIV positive by going around and saying 'yes' or 'no'.
Published on:
16 July, 2024
Prophylaxis treatment of a patient was discontinued after three years in 1987 because of the risks that immune-suppressive effects would follow.
Published on:
08 October, 2024
Dr Aronstam stated that reports of a hepatitis outbreak at Treloar's had been overstated.
Published on:
16 July, 2024
Dr Aronstam stated, in reference to a Treloar's student, that "he is realistic about AIDS and feels as I do that the benefits of treatment far outweigh the small risk of acquiring this condition".
Published on:
16 July, 2024
A student at Treloar's recalled that pupils were told that they were infected with HIV in the presence of other pupils who had tested negative. He was wrongly informed that he was positive.
Published on:
16 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
1967
Page
1968
Page
1969
Page
1970
Current page
1971
Page
1972
Page
1973
Page
1974
Page
1975
…
Next page
Next
Last page
Last